Home » Topics » Immune, BioWorld Science

Immune, BioWorld Science
RSS

SangStat's Thymoglobulin nearing phase III trials completion

Aug. 9, 1996

Peptech issued U.S. patent for GMDP as antiinflammatory agent

Aug. 9, 1996

American Home Products claims rapamycin compounds

Aug. 9, 1996

Immunostimulant series described by Takeda

Aug. 9, 1996

Biogal describes cyclosporin emulsions

July 26, 1996

Rapamycin esters from American Home Products

July 26, 1996

Immunoregulatory peptides with special binding properties

July 26, 1996

HSV proteins as immune resonse regulators

July 26, 1996

Ono's Ono-4057 shows immunosuppressive effects in preclinical trials

July 19, 1996

SmithKline Beecham's DTaP vaccine receives unanimous advisory committee approval

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...